Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioIntegral Surgical is a private Canadian medical device company focused on all-biological cardiovascular implants for pediatric and adult patients. The company develops and manufactures cardiac and vascular surgery products, including biologic valves, valved conduits, vascular conduits, and pericardial patches used in complex cardiovascular reconstruction and valve replacement procedures. Its portfolio is positioned around biocompatible, quick-to-implant devices intended to address limitations of synthetic alternatives, particularly in high-risk and congenital settings. BioIntegral Surgical markets products such as BioMitral, BioConduit, BioPulmonic Conduit, injectable biopulmonic devices, VersaFlex, and No-React Patch. The business appears to be commercially active rather than a therapeutics developer, with no conventional drug pipeline or clinical-stage pharmaceutical assets identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioIntegral Surgical.